| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 725,595 | 713,955 | 683,498 | 648,748 | | Cost of Revenue | 138,824 | 147,959 | 133,983 | 141,399 | | | Gross Profit | 586,771 | 565,996 | 549,515 | 507,349 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 54,794 | 52,264 | 49,423 | 48,277 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 20,000 | 9,000 | 5,000 | 3,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 511,977 | 504,732 | 495,092 | 456,072 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 511,977 | 504,732 | 495,092 | 456,072 | | Interest Expense | 300,667 | 303,549 | 292,256 | 272,129 | | Income Before Tax | 211,310 | 201,183 | 202,836 | 183,943 | | Income Tax Expense | 83,647 | 76,905 | 80,928 | 73,240 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 127,663 | 124,278 | 121,908 | 110,703 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 127,663 | 124,278 | 121,908 | 110,703 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $127,663 | $124,278 | $121,908 | $110,703 |
|
0.45% Nasdaq 
0.20%
Income Statement
